Abnormal myelocytic cell development in interleukin-2 (IL-2)-deficient mice: Evidence for the involvement of IL-2 in myelopiesis

Blood

Volumn 91, Issue 8, 1998, Pages 2935-2947

  Reya, Tannishtha ^a   Contractor, Nikhat V ^a   Couzens, Matthew S ^a   Wasik, Mariusz A ^a   Emerson, Stephen G ^a   Carding, Simon R ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

ANIMAL CELL; ARTICLE; GRANULOCYTE; IMMUNE DEFICIENCY; IN SITU HYBRIDIZATION; LEUKOCYTE DIFFERENTIAL COUNT; MACROPHAGE; MOUSE; MYELOBLAST; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE;

EID: 0032522965     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.8.2935.2935_2935_2947     Document Type: Article

References (60)

1. Morgan DA, Ruscetti FW, Gallo R: Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193:1007, 1976
2. Smith K: Interleukin 2: Inception, impact, and implications. Science 240:1169, 1988
3. Jung LKL, Hara T, Fu SM: Detection and functional studies of p60-65 (Tac antigen) on activated human B cells. J Exp Med 160:1597, 1984
4. Longo DL, Gelman EP, Cossman J, Young RA, Gallo RC, O'Brien SJ, Matis LA: Isolation of HTLV-transformed B-lymphocyte clone from a patient with HTLV-associated adult T cell leukemia. Nature 310:505, 1984
5. Muraguchi A, Kehri JH, Longo DL, Volkman DJ, Smith KA, Fauci AS: Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function. J Exp Med 161:181, 1985
6. Herrmann F, Cannistra SA, Levine H, Griffin JD: Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells. J Exp Med 162:1111, 1985
7. Birchenall-Sparks MC, Farrar WL, Rennick D, Kilian PL, Ruscetti FW: Regulation of expression of the interleukin-2 receptor on hematopoietic cells by interleukin-3. Science 233:455, 1986
8. Koyasu S, Yodoi J, Nikaido T, Tagaya Y, Taniguchi Y, Honjo T, Yahara I: Expression of interleukin 2 receptors on interleukin 3-dependent cell lines. J Immunol 136:984, 1986
9. Riedel D, Lindemann A, Brach MA, Mertelsmann R, Herrmann F: Cytokine induction of CD4 and CD25 on the surface of human eosinophils. Immunology 70:258, 1990
10. Espinoza-Delgardo I, Ortaldo JR, Winkler-Pickett R, Sugamura K, Varesio L, Longo DL: Expression and role of p75 interleukin 2 receptor on human monocytes. J Exp Med 171:1821, 1990
11. Ohashi Y, Takeshita T, Nagata K, Mori S, Sugamura K: Differential expression of the IL-2 receptor subunits p55 and p75 on various populations of primary peripheral blood mononuclear cells. J Immunol 143:3548, 1989
12. Henney CS, Kuribayashi K, Kern DE, Gillis S: Interleukin-2 augments natural killer cell activity. Nature 291:335, 1981
13. Domzig W, Stadler BM, Herbermann RB: Interleukin-2 dependence of human natural killer (NK) cell activity. J Immunol 130:1970, 1983
14. Robb RJ: Interleukin-2: The molecule and its function. Immunol Today 5:203, 1984
15. Carding SR, Reya T: Cytokines in the fetal thymus, in Nicolic-Zugic J (ed): Intrathymic T-Cell Development. Austin, TX, R.G. Landes, 1994, p 46
16. Rolink A, Grawunder U, Winkler TH, Karasuyama H, Melchers F: IL-2 receptor a chain (CD25, TAC) expression defines a crucial stage in pre-B cell development. Int Immunol 6:1257, 1994
17. Chen J, Ma A, Young F, Alt F: IL-2 receptor alpha chain expression during early B lymphocyte differentiation. Int Immunol 6:1265, 1994
18. Reya T, Yang-Snyder JA, Rothenberg EV, Carding SR: Regulated expression and function of CD 122 (interleukin-2/intereukin-15R-β) during lymphoid development. Blood 87:190, 1996
19. DiSanto JP, Müller W, Guy-Grand D, Fischer A, Rajewsky K: Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain. Proc Natl Acad Sci USA 92:377, 1995
20. Suzuki H, Duncan GS, Takimoto H, Mak TW: Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2-receptor β chain. J Exp Med 185:499, 1997
21. Pericle F, Liu JH, Diaz JI, Blanchard DK, Wei S, Forni G, Djeu JY: Interleukin-2 prevention of apoptosis in human neutrophils. Eur J Immunol 24:440, 1994
22. Malkovsky M, Loveland B, North M, Asherson GL, Gao L, Ward P, Fiers W: Recombinant interleukin-2 directyl augments the cytotoxicity of human monocytes. Nature 325:262, 1987
23. Djeu JY, Liu JH, Wei S, Rui H, Pearson CA, Leonard WJ, Blanchard DK: Function associated with IL-2 receptor-beta on human neutrophils. Mechanism of activation of antifungal activity against Candida albicans by IL-2. J Immunol 150:960, 1993
24. Wei S, Blanchard DK, Rui H, Pearson CA, Leonard WJ: Function associated with IL-2 receptor-β on human neutrophils: Mechanism of activation of antifungal activity against Candida albicans by IL-2. J Immunol 150:1979, 1993
25. Wei S, Liu JH, Blanchard DK, Djeu JY: Induction of IL8 gene expression in human polymorphonuclear neutrophils by recombinant IL-2. J Immunol 152:3630, 1994
26. Espinoza-Delgado I, Bosco MC, Musso T, Gusella GL, Longo DL, Varesio L: Interleukin-2 and human monocyte activation. J Leukoc Biol 57:13, 1995
27. Morrone G, Bond HM, Cuomo C, Agosti V, Petrella A, Pagnano AM, Della Corte A, Marasco O, Venuta S: Differential regulation of the expression of interleukin-2 receptor γ-chain during the in vitro differentiation of human myeloid cells. Biochem J 308:909, 1995
28. Schaafsma MR, Fibbe WE, Van Der Harst D, Duinkerken N, Brand A, Osanto S, Franks CR, Willemze R, Falkenberg JHF: Increased numbers of circulating haematopoietic progenitor cells after treatment with high-dose interleukin-2 in cancer patients. Br J Haematol 76:180, 1990
29. Gambacorti-Passerini C, Hank JA. Borchert A, Moore K, Malkovska V, Sondel P: In vivo effects of multiple cycles of recombinant interleukin-2 (IL-2) on peripheral granulocyte-macrophage hematopoietic progenitors circulating in the blood of cancer patients. Tumori 77:420, 1991
30. Tritarelli E, Rocca E, Testa U, Boccoli G, Camagna A, Calabresi F, Peschle C: Adoptive immunotherapy with high-dose interleukin-2: Kinetics of circulating progenitors correlates with interleukin-6, granulocyte colony stimulating factor level. Blood 77:741, 1991
31. Heslop HE, Duncombe AS, Reittie JE, Bello-Femandez C, Gottlieb DJ, Prentice HG, Mehta AB, Hoffbrand AV, Brenner MK: Interleukin 2 infusion induces haemopoietic growth factors and modifies marrow transplantation. Br J Haematol 77:237, 1991
32. Baccarini M, Schwinger M, Lohmann-Matthes M-L: Effect of human recombinant IL-2 on murine macrophage precursors. J Immunol 142:118, 1989
33. Michalevicz R, Campana D, Katz FE, Janossy G, Hoffbrand AV: Recombinant interleukin 2 and anti-Tac influence the growth of enriched multipotent hemopoietic progenitors: Proposed hypothesis for different responses in early and late progenitors. Leuk Res 12:113, 1988
34. Naldini A, Fleischmann WR, Bailas ZK, Klimpel KD, Kumpel GR: Interleukin 2 inhibits in vitro granulocyte-macrophage colony formation. J Immunol 139:1880, 1987
35. Takahashi M, Oshimi K, Saito H, Mizoguchi H: Inhibition of human granulocyte-macrophage colony formation by interleukin-2 treated lymphocytes. Exp Hematol 16:226, 1988
36. Carron JA, Cawley JC: IL-2 abolishes fibroblast proliferation in long-term bone marrow cultures by inhibition of an accessory cell. Br J Haematol 79:377, 1991
37. Estrov Z, Roifman C, Mills G, Grunberger T, Gelfand EW, Freedman MH: The regulatory role of interleukin-2-responsive T lymphocytes on human marrow granulopoiesis. Blood 69:1161, 1987
38. Burdach S, Shatsky M, Wgaenhorst B, Levitt L: Receptor-specific modulation of myelopoiesis by recombinant DNA-derived interleukin 2. J Immunol 139:452, 1987
39. Heslop HE, Price GM, Prentice HG, Cordingley FT, Web ADB, Hoffbrand AV, Brenner MK: In vitro analysis of the interaction of recombinant IL-2 with regenerating lymphoid and myeloid cells after allogeneic marrow transplantation. J Immunol 140:3461, 1988
40. Contractor NV, Bassiri H, Reya T, Park AY, Baumgart DC, Wasik M, Emerson SG, Carding SR: Lymphoid hyperplasia, autoimmunity and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic Interleukin 2-deficient mice. J Immunol 160: 385, 1998
41. Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I: Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352:621, 1991
42. Belles C, Kuhl AL, Donoghue A, Sano Y, O'Brien RL, Born W, Bottomly K, Carding SR: Bias in the γδ T cell response to Listeria monocytogenes. J Immunol 156:4280, 1996
43. Kono T, Doi T, Yamada G, Hatekayama M, Minamoto S, Tsudo M, Miyasaka M, Miyata T, Taniguchi T: Murine interleukin 2 receptor β chain: Dysregulated gene expression in lymphoma line EL-4 caused by a promoter insertion. Proc Natl Acad Sci USA 87:1806, 1990
44. Spooncer E, Eliason J, Dexter TM: Long-term mouse bone marrow cultures, in Testa NG, Molineux G (eds): Haemopoiesis: A Practical Approach. Oxford, UK, IRL, 1993, p 55
45. Hestdal K, Ruscetti FW, Ihle JN, Jacobsen SE, Dubois CM, Kopp WC, Longo DL, Keller JR: Characterization and regualtion of RB6-8C5 antigen expression on murine bone marrow cells. J Immunol 147:22, 1991
46. Springer T, Galfre G, Secher DS, Milstein C: Mac-1 : A macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol 9:301, 1979
47. Ralph P, Ho M-K, Litcofsky PB, Springer TA: Expression and induction in vitro of macrophage differentiation antigens on murine cell lines. J Immunol 130:108, 1983
48. Reya T, Bassiri H, Biancaniello R, Carding SR: Thymic stromal cell abnormalities and dysregulated T cell development in IL-2-deficient mice. Dev Immunol (in press)
49. + T cells. Eur J Immunol 25:3053, 1995
50. Krämer S, Schimpl A, Hunig T: Immunopathology of interleukin (IL) 2-deficient mice: Thymus dependence and supression by thymusdepedent cells with and intact IL-2 gene. J Exp Med 182:1769, 1995
51. Metcalf D: The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 339:27, 1989
52. Dranoff G, Crawford AD, Sadelain M, Ream B, Rashid A, Bronson RT, Dickersin GR, Bachurski CJ, Mark EL, Whitsett JA, Mulligan RC: Involvement of granulocyte-macrophage colony stimulating factor in pulmonary homeostasis. Science 264:713. 1994
53. Stanley E, Lieschke GJ, Grail D, Metcalf D, Hodgson G, Gall JAM, Maher DW, Cebon J, Sinickas V, Dunn AR: Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 91:5592, 1994
54. Metcalf D: Hematopoietic regulators: Redundancy or subtlety? Blood 82:3513, 1993
55. Smith L, Weissman I, Heimfeld S: Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc Natl Acad Sci USA 88:2788, 1991
56. Uchida N, Weismman I: Searching for hematopoietic stem cells: Evidence that Thy-1.1lo Lin-Sca-1+ cells are the only stem cells in C57BL/6Ka-Thy-1.1 bone marrow. J Exp Med 175:175, 1992
57. Suzuki H, Kundig TM, Furlonger C, Wakeman A, Timms E, Matsuyama T, Schmits R, Simard JJL, Ohashi P, Griesser H, Taniguchi T, Paige CJ, Mak TW: Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 268:1472, 1995
58. Horak I, Löhler J, Ma A, Smith KA: Interleukin-2 deficient mice: A new model to study autoimmunity and self-tolerance. Immunol Rev 148:35, 1995
59. Tavassoli M: Embryonic and fetal hemopoiesis: An overview. Blood Cells 1:269, 1991
60. Weinberg KP, Parkman R: Severe combined immunodeficiency due to a specific defect in the production of interleukin-2. N Engl J Med 322:1718, 1990